Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)
3.050
0.00 (0.00%)
At close: Oct 21, 2025
Sabaa International Company for Pharmaceutical and Chemical Industry Company Description
Sabaa International Company for Pharmaceutical and Chemical Industry engages in the manufacture and sale of generic medicines in Egypt.
It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets, such as Claudol and Flamogen E.C.T.
The company also offers OTCs, food supplements, and veterinary products, as well as medicine trials services.
The company was founded in 2000 and is based in Cairo, Egypt.
Sabaa International Company for Pharmaceutical and Chemical Industry
| Country | Egypt |
| Founded | 2000 |
| Industry | Pharmaceutical Preparations |
| Employees | 165 |
| CEO | Sahal Morsi Al-Damrawi |
Contact Details
Address: 6 Ahmed Shaker Street Cairo Egypt | |
| Phone | 20 2 4148529 |
| Website | sabaapharmagroup.com |
Stock Details
| Ticker Symbol | SIPC |
| Exchange | Egyptian Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EGP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sahal Morsi Al-Damrawi | Chief Executive Officer |
| Ibrahim Nawar | Head of Investor Relations |